New National Emphysema Treatment Trial paradigm of health care financing administration-sponsored clinical research trials: Advances and dilemmas

Journal of Investigative Medicine

Volumn 50, Issue 2, 2002, Pages 95-100

  Brenner, Matthew ^a   Jones, Blanding ^a   Daneschvar, H L ^a   Triff, Stephanie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ethics; HCFA; Lung; NETT; Trials

Indexed keywords

ARTICLE; CHRONIC LUNG DISEASE; CLINICAL RESEARCH; COST; EMPHYSEMA; HEALTH CARE DELIVERY; HUMAN; LUNG RESECTION; LUNG SURGERY; MEDICAL ETHICS; PATIENT SELECTION;

EID: 0036203535     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Rationale and design of The National Emphysema Treatment Trial: A prospective randomized trial of lung volume reduction surgery
2. Rationale and design of the National Emphysema Treatment Trial (NETT): A prospective randomized trial of lung volume reduction surgery
3. Clinical research: Assessing the future in a changing environment - Summary report of conference sponsored by the American Medical Association Council on Scientific Affairs, Washington, DC, March 1996
4. Estimated growth of lung volume reduction surgery among Medicare enrollees: 1994 to 1996
5. Coronary-artery bypass surgery: It works, but why?
6. Coronary artery bypass surgery
7. Landmarks in the development of coronary artery bypass surgery
8. Coronary-artery bypass surgery
9. Controversy of the decade: Coronary artery bypass graft (CABG) surgery
10. Survival following bypass graft surgery
11. Effect of coronary artery bypass graft surgery on survival
12. Critical analysis of coronary artery bypass graft surgery: A 30-year journey
13. Clinical experience and predicting survival in coronary disease
14. Predicting outcome in coronary disease: Statistical models versus expert clinicians
15. 1995 Coronary artery bypass risk model: The Society of Thoracic Surgeons Adult Cardiac National Database
16. The influence of coronary artery bypass surgery on survival
17. The influence of coronary bypass grafting on longevity
18. Lung-volume reduction surgery for severe emphysema
19. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease
20. Should lung volume reduction for emphysema be unilateral or bilateral?
21. Economic aspects of lung volume reduction surgery
22. Clinical experimentation: Lessons from lung volume reduction surgery
23. Lung volume reduction surgery for emphysema: Out on a limb without a NETT
24. Lung volume reduction surgery: This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, May 1996
25. Capitation, managed care, and chronic obstructive pulmonary disease
26. Is volume reduction surgery appropriate in the treatment of emphysema? No
27. Lung-volume reduction surgery for end-stage chronic obstructive pulmonary disease
28. Evaluation and research in lung volume reduction surgery
29. Lung volume reduction surgery: Answering the crucial questions
30. Economic analysis of lung volume reduction surgery as part of the National Emphysema Treatment Trial: NETT Research Group
31. Monitoring and ensuring safety during clinical research
32. Unilateral thoracoscopic laser pneumoplasty of diffuse bullous emphysema
33. Reduction pneumonoplasty for emphysema: Early results
34. In vitro comparison between Argon Beam Coagulator and Nd:YAG laser in lung contraction therapy
35. Functional comparison of unilateral versus bilateral lung volume reduction surgery
36. Survival after unilateral versus bilateral lung volume reduction surgery for emphysema
37. Comparison of short-term functional outcomes following unilateral and bilateral lung volume reduction surgery
38. Effect of bovine pericardial strips on air leak after stapled pulmonary resection
39. A randomized, prospective trial of stapled lung reduction versus laser bullectomy for diffuse emphysema
40. Comparison of staged thoracoscopy and median sternotomy for lung volume reduction
41. No-cut thoracoscopic lung plication: A new technique for lung volume reduction surgery
42. Buttressing the staple line in lung volume reduction surgery: A randomized three-center study
43. Equipoise and the ethics of the Canadian Lung Volume Reduction Surgery Trial study: Should there be a randomized, controlled trial to evaluate lung volume reduction surgery?
44. Freedman's "clinical equipoise" and "sliding-scale all-dimensions-considered equipoise"
45. Outcome of Medicare patients with emphysema selected for, but denied, a lung volume reduction operation
46. Evaluation of patients with emphysema for lung volume reduction surgery: Washington University Emphysema Surgery Group
47. For and against: Clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial
48. Why should we include women and minorities in randomized controlled trials?
49. A study in contrasts: Eligibility criteria in a twenty-year sample of NSABP and POG clinical trials - National Surgical Adjuvant Breast and Bowel Program: Pediatric Oncology Group
50. Lung volume reduction surgery and airflow limitation
51. Pulmonary emphysema: Comparison of preoperative quantitative CT and physiologic index values with clinical outcome after lung-volume reduction surgery
52. Radiology of pulmonary emphysema and lung volume reduction surgery
53. Two years' outcome of lung volume reduction surgery in different morphologic emphysema types
54. Predictors of improvement in FEV1 (forced expiratory volume in 1s) after lung volume reduction surgery
55. Patient selection criteria for lung volume reduction surgery
56. Functional and morphological heterogeneity of emphysema and its implication for selection of patients for lung volume reduction surgery
57. Insight on emphysema: The first 300 cases of surgical treatment
58. Survival following bilateral staple lung volume reduction surgery for emphysema
59. Dyspnea response following bilateral thoracoscopic staple lung volume reduction surgery
60. Equipoise and the ethics of clinical research
61. Uncertainty about clinical equipoise: Clinical equipoise and the uncertainty principles both require further scrutiny